The TB and clinical monitoring team tcmt of the international laboratory branch dght GHC performs evaluation of clinical assays used by laboratories supported by the US president emergency plan for…
Ended Awarded Last action
- Contract number
- 75D30124F00069
- Awardee
-
Agilent Technologies Inc. UEI SD9JZ9S7MEA6 Part of Agilent Technologies, Inc.
- Awarding agency
-
CDC Pittsburgh
Centers for Disease Control and Prevention, Department of Health and Human Services
- Obligated
- $62,820
Award facts
- Opportunity
-
- HCWBB2024EJH00240 Solicitation number
- Contract value 78% obligated
-
- $62,819.84 Current, with exercised options
- $80,711.16 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Marshallton, DE 19808, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $62,820 |
About this award
The Centers for Disease Control and Prevention Pittsburgh issued a delivery order to Agilent Technologies Inc. on August 19, 2024, with a ceiling value of $80,711.16 under the GSA Multiple Award Schedule for evaluation of clinical assays used by laboratories supported by the US President's Emergency Plan for AIDS Relief in resource-limited countries.
Place of performance is Marshallton, Delaware. The order is firm fixed price with an ultimate completion date of August 18, 2029. The work supports the TB and Clinical Monitoring Team of the International Laboratory Branch within CDC's Division of Global HIV and Tuberculosis, evaluating clinical assay performance at PEPFAR-supported laboratory sites.
Description
The TB and clinical monitoring team tcmt of the international laboratory branch dght GHC performs evaluation of clinical assays used by laboratories supported by the US president emergency plan for aids relief
Quick answers
Who was awarded contract 75D30124F00069?
75D30124F00069 was awarded to Agilent Technologies Inc. by CDC Pittsburgh (Centers for Disease Control and Prevention) on August 19, 2024.
How much is contract 75D30124F00069 worth?
The government has obligated $62,820 on 75D30124F00069. Its potential value, with all options, is $80,711.
Is contract 75D30124F00069 an order under another contract?
Yes. 75D30124F00069 is a delivery order under GS07F0564X, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75D30124F00069 competed?
The extent of competition for 75D30124F00069 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award